The company has continued to invest in this smaller but strategically important business line
Every 2 to 3 hours during waking hours
If you do not see the icon in the dose window, insert the needle back into your skin and finish your injection
GLP-1 Receptor Agonists (e.g., semaglutide, liraglutide) Increase insulin secretion in response to food Reduce glucagon release (which lowers blood sugar) Slows gastric emptying (which helps with post-meal glucose excursions) Reduces appetite and induces satiety which leads to weight loss GLP-1/GIP Receptor Agonists (e.g., tirzepatide) GLP-1 effects (same as above) GIP effect: further enhances insulin secretion Both medications help with blood sugar control and weight loss, but Mounjaros dual mechanism may offer stronger effects on insulin secretion, which improves A1c levels
Practical access strategies For patients in markets where both peptides are available, tirzepatide is the practical choice due to established availability, known dosing protocols, extensive clinical experience, and insurance coverage pathways
The STEP trials, focusing on weight management in patients with obesity, similarly reported systolic blood pressure decreases of 48 mmHg with semaglutide 2.4 mg compared to placebo